AMEH - Apollo Medical GAAP EPS of $0.31 misses by $0.03 revenue of $337.2M beats by $25.91M
2023-05-08 16:33:56 ET
- Apollo Medical press release ( NASDAQ: AMEH ): Q1 GAAP EPS of $0.31 misses by $0.03 .
- Revenue of $337.2M (+28.1% Y/Y) beats by $25.91M .
- Adjusted EBITDA of $29.8 million, compared to $34.4 million for the prior-year quarter
- EBITDA of $24.0 million for the quarter ended March 31, 2023, compared to $23.7 million for the quarter ended March 31, 2022.
-
As of March 31, 2023, ApolloMed's cash and cash equivalents and investments in marketable securities were $278.7 million, working capital was $292.7 million, and total stockholders' equity was $563.2 million; compared to cash and cash equivalents and investments in marketable securities of $293.6 million, working capital of $287.8 million and total stockholders' equity of $555.0 million, respectively, as of December 31, 2022.
For further details see:
Apollo Medical GAAP EPS of $0.31 misses by $0.03, revenue of $337.2M beats by $25.91M